NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Xenetic Biosciences Inc (NASDAQ: XBIOW)

 
XBIOW Technical Analysis
4
As on 18th May 2022 XBIOW Share Price closed @ 1.00 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 2.05 & Sell for SHORT-TERM with Stoploss of 1.73 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

XBIOW Share Price

Open 1.00 Change Price %
High 1.00 1 Day 0.00 0.00
Low 1.00 1 Week 0.00 0.00
Close 1.00 1 Month 0.00 0.00
Volume N/A 1 Year 0.59 143.90
52 Week High 5.85 | 52 Week Low 0.41
 
NASDAQ USA Most Active Stocks
AMD 96.28 -6.04%
AAPL 140.82 -5.64%
BRQS 0.19 11.76%
SNDL 0.41 -6.82%
GNUS 0.78 13.04%
AGRI 2.92 8.96%
BBIG 3.05 6.64%
ENDP 0.62 -46.55%
NVDA 169.38 -6.82%
SOFI 7.23 2.55%
 
NASDAQ USA Top Gainers Stocks
NDRAW 0.03 200.00%
EYESW 0.48 92.00%
SMIHW 0.15 87.50%
ZJZZT 38.00 78.82%
THCAW 0.33 73.68%
WKSPW 0.63 57.50%
TMPMW 0.11 57.14%
BROGW 0.42 55.56%
PPHPR 0.14 55.56%
EFTRW 0.23 53.33%
 
NASDAQ USA Top Losers Stocks
PTRAW 0.23 -89.59%
VENAW 0.05 -50.00%
ALACW 0.01 -50.00%
BTAQW 0.01 -50.00%
ENDP 0.62 -46.55%
MDGSW 0.21 -44.74%
ALACR 0.04 -42.86%
IKNX 19.52 -42.42%
NLITW 0.09 -40.00%
ROVRW 1.30 -34.34%
 
 
XBIOW
Daily Charts
XBIOW
Intraday Charts
Whats New @
Bazaartrend
XBIOW
Free Analysis
 
XBIOW Important Levels Intraday
RESISTANCE1.00
RESISTANCE1.00
RESISTANCE1.00
RESISTANCE1.00
RESISTANCE1.00
RESISTANCE1.00
RESISTANCE1.00
RESISTANCE1.00
 
XBIOW Target for Month May
4th UP TARGET5.97
3rd UP TARGET4.38
2nd UP TARGET3.39
1st UP TARGET2.41
1st DOWN TARGET-0.41
2nd DOWN TARGET-1.39
3rd DOWN TARGET-2.38
4th DOWN TARGET-3.97
 
XBIOW Weekly Target
4th UP TARGET4.47
3rd UP TARGET3.36
2nd UP TARGET2.67
1st UP TARGET1.98
1st DOWN TARGET0.02
2nd DOWN TARGET-0.67
3rd DOWN TARGET-1.36
4th DOWN TARGET-2.47
 
XBIOW Target for Year 2022
4th UP TARGET12.02
3rd UP TARGET8.49
2nd UP TARGET6.3
1st UP TARGET4.12
1st DOWN TARGET-2.12
2nd DOWN TARGET-4.3
3rd DOWN TARGET-6.49
4th DOWN TARGET-10.02
 
 
XBIOW Other Details
Segment EQ
Market Capital 0.00
Sector Other
Industry Other
Offical website >
 
XBIOW Address
XBIOW
 
XBIOW Latest News
 
Your Comments and Response on Xenetic Biosciences Inc
 
XBIOW Business Profile
Xenetic Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, research, and development of next-generation biologic drugs and novel orphan oncology therapeutics. The company's lead investigational product candidate is oncology therapeutic XBIO-101 (sodium cridanimod) for the treatment of progestin resistant endometrial cancer. It is also developing ErepoXen, a drug using PolyXen platform technology for the treatment of anemia in chronic kidney disease patients. The company has collaboration agreements with Takeda Pharmaceutical Co. Ltd., Serum Institute of India Limited, PJSC Pharmsynthez, and SynBio LLC. Xenetic Biosciences, Inc. is headquartered in Framingham, Massachusetts. Address:
 
2005-2021 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service